Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LKQ CORP Director's Dealing 2011

Nov 30, 2011

30750_dirs_2011-11-30_06a9c75f-7a64-4b1c-b02f-7c9788d020ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LKQ CORP (LKQX)
CIK: 0001065696
Period of Report: 2011-11-28

Reporting Person: HOLSTEN JOSEPH M (Director, Co-Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-28 Common Stock S 10300 $28.73 Disposed 239169 Direct
2011-11-29 Common Stock S 39960 $29.08 Disposed 199209 Direct
2011-11-30 Common Stock M 13354 $10.0575 Acquired 212563 Direct
2011-11-30 Common Stock M 16000 $11.955 Acquired 228563 Direct
2011-11-30 Common Stock S 700 $30.0207 Disposed 227863 Direct
2011-11-30 Common Stock S 28654 $30.0007 Acquired 199209 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-30 Stock Option (right to buy)(01/12/2007 grant) $10.0575 M 13354 Disposed 2017-01-12 Common Stock (13354) Direct
2011-11-30 Stock Option (right to buy)(01/09/2009 grant) $11.955 M 16000 Disposed 2019-01-09 Common Stock (16000) Direct

Footnotes

F1: The price reflects the weighted average sale price of the transaction reported. The price range of such transactions was $28.62 to $28.80. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares sold at each separate price.

F2: The price reflects the weighted average sale price of the transaction reported. The price range of such transactions was $28.84 to $29.31. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares sold at each separate price.

F3: This sale was affected pursuant to a 10b5-1 plan.

F4: The option is exercisable with respect to 10% of the number of shares subject to the option on each six-month anniversary of the grant date.